IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
IOL Chemicals and Pharmaceuticals Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Ludhiana, PU, IN. The stock last traded at $165.58, down 0.27% on the session, giving a market capitalisation of $48.60B. Its beta of 0.48 implies it has historically moved less than the broad market.
Established in 1986 and headquartered in Ludhiana, India, IOL Chemicals and Pharmaceuticals Limited operates as a global manufacturer and supplier of diverse pharmaceutical and chemical products. Its pharmaceutical portfolio encompasses a wide array of active pharmaceutical ingredients (APIs), featuring prominent pain and fever relievers such as ibuprofen, ibuprofen lysinate, ibuprofen sodium, and dex-ibuprofen. The company also provides other crucial APIs, including metformin hydrochloride, clopidogrel bisulphate, pantoprazole sodium, ursodeoxycholic acid, losartan potassium, gabapentin, levetiracetam, lamotrigine, and fenofibrate. These compounds are integral to treatments addressing various conditions, such as inflammation, pain relief, fever reduction, diabetes, platelet aggregation, cholesterol management, seizures, gallstones, and gastric acid inhibition. In addition to pharmaceuticals, IOL supplies specialized industrial chemicals like ethyl acetate, iso butyl benzene, acetyl chloride, and mono chloro acetic acid. These chemicals are widely utilized across numerous industries, including food processing, flexible packaging, pharmaceuticals, textiles, ink, paint, pesticides, and as chemical intermediates.
IOL Chemicals and Pharmaceuticals Limited is most often compared with the following Healthcare names: